Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2018 Results And Provides 2019 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Bausch Health Companies (BHC) PT Lowered to $25 at BMO Capital
February 21, 2019 9:35 AM ESTBMO Capital analyst Gary Nachman lowered the price target on Bausch Health Companies (NYSE: BHC) to $25.00 (from $26.00) while maintaining a Market Perform rating.
Nachman notes BHC delivered relatively in-line 4Q and 2019 guidance overall roughly in-line with expectations, although bottom-end of revenue range... More
Bausch Health Co. Inc. (BHC) Q4 Revenue Tops Views, Guidance Misses at Mid-Point
February 20, 2019 7:05 AM ESTBausch Health Co. Inc. (NYSE: BHC) reported Q4 EPS of ($0.98), may not compare to the analyst estimate of $0.84. Revenue for the quarter came in at $2.12 billion versus the consensus estimate of $2.08 billion.
GUIDANCE:
Bausch Health Co. Inc. sees FY2019 revenue... More
